Your browser doesn't support javascript.
The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study.
Eman, Ali; Balaban, Onur; Süner, Kezban Ö; Cirdi, Yasar; Sahin, Fatih; Demir, Gürkan; Peksen, Özge; Musmul, Ahmet; Erdem, Ali F.
  • Eman A; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Balaban O; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Süner KÖ; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Cirdi Y; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Sahin F; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Demir G; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Peksen Ö; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Musmul A; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
  • Erdem AF; From the Department of Anesthesiology and Reanimation (Eman, Balaban, Sahin, Demir, Peksen, Erdem); from the Department of Intensive Care (Süner), Sakarya Training and Research Hospital; from the Department of Intensive Care (Cirdi), faculty of Medicine, Sakarya University, Sakarya; and from the Dep
Saudi Med J ; 43(7): 715-722, 2022 Jul.
Статья в английский | MEDLINE | ID: covidwho-1955133
ABSTRACT

OBJECTIVES:

To assess the effect of different thromboprophylaxis regimens on clinical outcomes and mortality of critical ill patients with coronavirus disease -19 (COVID-19).

METHODS:

We investigated the medical records of patients with positive COVID-19 (using polymerase chain reaction test) who were admitted to the intensive care unit (ICU) at Sakarya University Hospital, Sakarya, Turkey, from March 2020 to January 2021. We included patients under anticoagulant therapy in the clinical course. The patients were allocated to 3 groups Group A - low-dose (prophylactic) low-molecular-weight-heparin (LMWH) therapy, Group B - high-dose (therapeutic) LMWH therapy, and patients that received aspirin additional to the high-dose (therapeutic) LMWH as Group C. Primary outcomes were overall mortality rates and length of stay (LOS) in ICU. Secondary outcomes were rates of major hemorrhagic and thrombotic events.

RESULTS:

Records of 475 patients were reviewed and 164 patients were included. No significant difference was detected in mortality rates between groups (p=0.135). Intensive care unit stay was 13 (9-24.5) days in Group A, 11 (8.75-23) days in Group B, and 13 (9-17) days in Group C without a significant difference (p=0.547). No significant difference was detected between groups in terms of thrombotic (p=0.565) and hemorrhagic events (p=0.615).

CONCLUSION:

A high-dose anticoagulation therapy and addition of aspirin to LMWH therapy did not decrease the mortality rates and LOS in ICU in critical ill COVID-19 patients. In addition, it did not increase the incidence of major hemorrhage and major thrombotic events.
Тема - темы
ключевые слова

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: Thrombosis / Venous Thromboembolism / COVID-19 Тип исследования: Когортное исследование / Экспериментальные исследования / Наблюдательное исследование / Прогностическое исследование / Рандомизированные контролируемые испытания Пределы темы: Люди Язык: английский Журнал: Saudi Med J Год: 2022 Тип: Статья

Документы, близкие по теме

MEDLINE

...
LILACS

LIS


Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: Thrombosis / Venous Thromboembolism / COVID-19 Тип исследования: Когортное исследование / Экспериментальные исследования / Наблюдательное исследование / Прогностическое исследование / Рандомизированные контролируемые испытания Пределы темы: Люди Язык: английский Журнал: Saudi Med J Год: 2022 Тип: Статья